141 related articles for article (PubMed ID: 12899522)
21. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
22. A 24-phenylsulfone analog of vitamin D inhibits 1alpha,25-dihydroxyvitamin D(3) degradation in vitamin D metabolism-competent cells.
Lechner D; Manhardt T; Bajna E; Posner GH; Cross HS
J Pharmacol Exp Ther; 2007 Mar; 320(3):1119-26. PubMed ID: 17182978
[TBL] [Abstract][Full Text] [Related]
23. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia.
Zhou C; Assem M; Tay JC; Watkins PB; Blumberg B; Schuetz EG; Thummel KE
J Clin Invest; 2006 Jun; 116(6):1703-12. PubMed ID: 16691293
[TBL] [Abstract][Full Text] [Related]
24. Potent, selective and low-calcemic inhibitors of CYP24 hydroxylase: 24-sulfoximine analogues of the hormone 1alpha,25-dihydroxyvitamin D(3).
Kahraman M; Sinishtaj S; Dolan PM; Kensler TW; Peleg S; Saha U; Chuang SS; Bernstein G; Korczak B; Posner GH
J Med Chem; 2004 Dec; 47(27):6854-63. PubMed ID: 15615534
[TBL] [Abstract][Full Text] [Related]
25. Potent, low-calcemic, selective inhibitors of CYP24 hydroxylase: 24-sulfone analogs of the hormone 1alpha,25-dihydroxyvitamin D3.
Posner GH; Crawford KR; Yang HW; Kahraman M; Jeon HB; Li H; Lee JK; Suh BC; Hatcher MA; Labonte T; Usera A; Dolan PM; Kensler TW; Peleg S; Jones G; Zhang A; Korczak B; Saha U; Chuang SS
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):5-12. PubMed ID: 15225738
[TBL] [Abstract][Full Text] [Related]
26. CYP24A1 as a potential target for cancer therapy.
Sakaki T; Yasuda K; Kittaka A; Yamamoto K; Chen TC
Anticancer Agents Med Chem; 2014 Jan; 14(1):97-108. PubMed ID: 23869781
[TBL] [Abstract][Full Text] [Related]
27. Calcitriol regulates the expression of the genes encoding the three key vitamin D3 hydroxylases and the drug-metabolizing enzyme CYP3A4 in the human fetal intestine.
Theodoropoulos C; Demers C; Delvin E; Ménard D; Gascon-Barré M
Clin Endocrinol (Oxf); 2003 Apr; 58(4):489-99. PubMed ID: 12641633
[TBL] [Abstract][Full Text] [Related]
28. Skin is an autonomous organ in synthesis, two-step activation and degradation of vitamin D(3): CYP27 in epidermis completes the set of essential vitamin D(3)-hydroxylases.
Schuessler M; Astecker N; Herzig G; Vorisek G; Schuster I
Steroids; 2001; 66(3-5):399-408. PubMed ID: 11179749
[TBL] [Abstract][Full Text] [Related]
29. Rat cytochrome P450C24 (CYP24) does not metabolize 1,25-dihydroxyvitamin D2 to calcitroic acid.
Horst RL; Omdahl JA; Reddy S
J Cell Biochem; 2003 Feb; 88(2):282-5. PubMed ID: 12520527
[TBL] [Abstract][Full Text] [Related]
30. Hepatic activation and inactivation of clinically-relevant vitamin D analogs and prodrugs.
Jones G; Byford V; West S; Masuda S; Ibrahim G; Kaufmann M; Knutson JC; Strugnell S; Mehta R
Anticancer Res; 2006; 26(4A):2589-95. PubMed ID: 16886668
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3-1alpha-hydroxylase activity and regulation of side-chain metabolism.
Cross HS; Peterlik M; Reddy GS; Schuster I
J Steroid Biochem Mol Biol; 1997 May; 62(1):21-8. PubMed ID: 9366495
[TBL] [Abstract][Full Text] [Related]
32. A local effect of CYP24 inhibition on lung tumor xenograft exposure to 1,25-dihydroxyvitamin D(3) is revealed using a novel LC-MS/MS assay.
Beumer JH; Parise RA; Kanterewicz B; Petkovich M; D'Argenio DZ; Hershberger PA
Steroids; 2012 Apr; 77(5):477-83. PubMed ID: 22285938
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of antiproliferative activity of 1alpha,25-dihydroxyvitamin D3 (analogs) by cytochrome P450 enzyme inhibitors is compound- and cell-type specific.
Zhao J; Tan BK; Marcelis S; Verstuyf A; Bouillon R
J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):197-202. PubMed ID: 8645629
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of vitamin D: current status.
DeLuca HF
Am J Clin Nutr; 1976 Nov; 29(11):1258-70. PubMed ID: 187053
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional synergism between vitamin D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase (CYP24) promoter.
Kerry DM; Dwivedi PP; Hahn CN; Morris HA; Omdahl JL; May BK
J Biol Chem; 1996 Nov; 271(47):29715-21. PubMed ID: 8939905
[TBL] [Abstract][Full Text] [Related]
36. CYP3A4 is a human microsomal vitamin D 25-hydroxylase.
Gupta RP; Hollis BW; Patel SB; Patrick KS; Bell NH
J Bone Miner Res; 2004 Apr; 19(4):680-8. PubMed ID: 15005856
[TBL] [Abstract][Full Text] [Related]
37. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium.
Bland R; Walker EA; Hughes SV; Stewart PM; Hewison M
Endocrinology; 1999 May; 140(5):2027-34. PubMed ID: 10218951
[TBL] [Abstract][Full Text] [Related]
38. 25-hydroxyvitamin D3 is an active hormone in human primary prostatic stromal cells.
Lou YR; Laaksi I; Syvälä H; Bläuer M; Tammela TL; Ylikomi T; Tuohimaa P
FASEB J; 2004 Feb; 18(2):332-4. PubMed ID: 14657005
[TBL] [Abstract][Full Text] [Related]
39. Affinity labeling of rat cytochrome P450C24 (CYP24) and identification of Ser57 as an active site residue.
Omdahl JL; Swamy N; Serda R; Annalora A; Berne M; Rayb R
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):159-62. PubMed ID: 15225765
[TBL] [Abstract][Full Text] [Related]
40. Hormonal regulation of 25-hydroxyvitamin D3-1alpha-hydroxylase and 24-hydroxylase gene transcription in opossum kidney cells.
Armbrecht HJ; Hodam TL; Boltz MA
Arch Biochem Biophys; 2003 Jan; 409(2):298-304. PubMed ID: 12504896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
